Determinants of Tumor Necrosis Factor Inhibitor Use in Juvenile Spondyloarthropathy and Impact on Clinical Disease Outcomes

OBJECTIVE: The objectives of this study were to characterize the reasons for tumor necrosis factor inhibitor (TNFi) initiation in patients with juvenile spondyloarthropathy (JSpA) and identify clinical correlates and to assess the effect of TNFi therapy on JSpA disease activity. METHODS: We conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliver, Melissa, Simard, Julia F., Lee, Tzielan, Gerstbacher, Dana, Sandborg, Christy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754014/
https://www.ncbi.nlm.nih.gov/pubmed/34647693
http://dx.doi.org/10.1002/acr2.11353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754014/
https://www.ncbi.nlm.nih.gov/pubmed/34647693
http://dx.doi.org/10.1002/acr2.11353

Ejemplares similares